CytoDyn (CYDY) 10-K/A 2022 FY Annual report (amended)

EXHIBIT 31.4

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Antonio Migliarese, certify that:

1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of CytoDyn Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: September 28, 2022	CYTODYN INC.
	(Registrant)
	By:	/s/ Antonio Migliarese
		Antonio Migliarese
		Chief Financial Officer